Notice NOT-DK-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-087 from the NIH Guide for Grants and Contracts

Notice NOT-MD-20-013 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-20-028 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications describing research focused on improving care and health-related quality of life for childhood, and adolescent and young adult (AYA) cancer survivors. Specifically, this FOA solicits mechanistic, observational, and intervention applications that focus on six key domains: (1) disparities in survivor outcomes; (2) barriers to follow-up care (e.g. access, adherence); (3) impact of familial, socioeconomic, and other environmental factors on survivor outcomes; (4) indicators for long-term follow-up needs related to risk for late effects, recurrence, and subsequent cancers; (5) risk factors and predictors of late/long-term effects of cancer treatment; and (6) development of targeted interventions to reduce the burden of cancer for pediatric/AYA survivors.

Funding Opportunity RFA-CA-20-027 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications describing research focused on improving care and health-related quality of life for childhood, and adolescent and young adult (AYA) cancer survivors. Specifically, this FOA solicits mechanistic, observational, and intervention applications that focus on six key domains: (1) disparities in survivor outcomes; (2) barriers to follow-up care (e.g. access, adherence); (3) impact of familial, socioeconomic, and other environmental factors on survivor outcomes; (4) indicators for long-term follow-up needs related to risk for late effects, recurrence, and subsequent cancers; (5) risk factors and predictors of late/long-term effects of cancer treatment; and (6) development of targeted interventions to reduce the burden of cancer for pediatric/AYA survivors.

Funding Opportunity PAR-20-138 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications requiring multi-project, synergistic collaborations blending multiple research approaches from outstanding multidisciplinary research teams. This Center of Excellence for Research on Complementary and Integrative Health (CERCIH) program is designed to support three or more highly meritorious projects that can offer significant scientific advantages and "synergy" that could not be achieved by supporting the same projects as individual research grants. Each CERCIH must be focused on questions of high relevance to the mission of NCCIH and high research priority based on the current Strategic Plan. Applications in response to this FOA may propose to involve human participants in mechanistic studies, but this FOA will not support clinical trials of efficacy or effectiveness.

Funding Opportunity PAR-20-140 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.

Notice NOT-HG-20-026 from the NIH Guide for Grants and Contracts

Notice NOT-HG-20-027 from the NIH Guide for Grants and Contracts

Notice NOT-HG-20-025 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-078 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-043 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-042 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-139 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Funding Opportunity RFA-AG-21-018 from the NIH Guide for Grants and Contracts. This FOA invites applications to create an Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC), serving the needs of NIA and the NIAs Artificial Intelligence and Technology Collaboratories for Aging (AITC). The AITCC will serve as a hub for the AITC program and will facilitate and coordinate trans-AITC activities.

Funding Opportunity RFA-AG-21-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program. The AITC program will serve as a national resource to promote the development and implementation of artificial intelligence approaches and technology through demonstration projects to improve care and health outcomes for older Americans, including persons with dementia (PWD) and their caregivers.

Notice NOT-RM-20-014 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-021 from the NIH Guide for Grants and Contracts

Notice NOT-MD-20-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DE-20-006 from the NIH Guide for Grants and Contracts. To elucidate the capacity of cells residing in the postnatal DOC tissues to acquire developmental plasticity to undergo lineage reprogramming (trans-differentiation) in vivo in response to injury and other types of environmental stress, and to generate functionally-competent cells of alternative lineage(s).